79 related articles for article (PubMed ID: 15797715)
1. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
[TBL] [Abstract][Full Text] [Related]
2. Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.
Chiasson-MacKenzie C; Morris ZS; Liu CH; Bradford WB; Koorman T; McClatchey AI
Genes Dev; 2018 Sep; 32(17-18):1201-1214. PubMed ID: 30143526
[TBL] [Abstract][Full Text] [Related]
3. Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.
Ali Khajeh J; Ju JH; Atchiba M; Allaire M; Stanley C; Heller WT; Callaway DJ; Bu Z
J Mol Biol; 2014 Jul; 426(15):2755-68. PubMed ID: 24882693
[TBL] [Abstract][Full Text] [Related]
4. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
[TBL] [Abstract][Full Text] [Related]
5. Emergence and Evolution of ERM Proteins and Merlin in Metazoans.
Shabardina V; Kashima Y; Suzuki Y; Makalowski W
Genome Biol Evol; 2020 Jan; 12(1):3710-3724. PubMed ID: 31851361
[TBL] [Abstract][Full Text] [Related]
6. Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function.
Moesslacher CS; Auernig E; Woodsmith J; Feichtner A; Jany-Luig E; Jehle S; Worseck JM; Heine CL; Stefan E; Stelzl U
Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37280085
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.
Lavado A; He Y; Paré J; Neale G; Olson EN; Giovannini M; Cao X
Development; 2013 Aug; 140(16):3323-34. PubMed ID: 23863479
[TBL] [Abstract][Full Text] [Related]
8. Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors.
Lavialle M; Aumann G; Anlauf E; Pröls F; Arpin M; Derouiche A
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12915-9. PubMed ID: 21753079
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability.
Riecken LB; Tawamie H; Dornblut C; Buchert R; Ismayel A; Schulz A; Schumacher J; Sticht H; Pohl KJ; Cui Y; Reis A; Morrison H; Abou Jamra R
Hum Mutat; 2015 Feb; 36(2):270-8. PubMed ID: 25504542
[TBL] [Abstract][Full Text] [Related]
10. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.
Wald FA; Oriolo AS; Mashukova A; Fregien NL; Langshaw AH; Salas PJ
J Cell Sci; 2008 Mar; 121(Pt 5):644-54. PubMed ID: 18270268
[TBL] [Abstract][Full Text] [Related]
11. Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF-induced cell scattering.
Naba A; Reverdy C; Louvard D; Arpin M
EMBO J; 2008 Jan; 27(1):38-50. PubMed ID: 18046454
[TBL] [Abstract][Full Text] [Related]
12. Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells.
D'Angelo R; Aresta S; Blangy A; Del Maestro L; Louvard D; Arpin M
Mol Biol Cell; 2007 Dec; 18(12):4780-93. PubMed ID: 17881735
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.
Martín-Villar E; Megías D; Castel S; Yurrita MM; Vilaró S; Quintanilla M
J Cell Sci; 2006 Nov; 119(Pt 21):4541-53. PubMed ID: 17046996
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.
Ardizzone A; Capra AP; Campolo M; Filippone A; Esposito E; Briuglia S
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625677
[TBL] [Abstract][Full Text] [Related]
16. PLPP/CIN-mediated NF2-serine 10 dephosphorylation regulates F-actin stability and Mdm2 degradation in an activity-dependent manner.
Kim JE; Lee DS; Kim TH; Park H; Kim MJ; Kang TC
Cell Death Dis; 2021 Jan; 12(1):37. PubMed ID: 33414453
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte morphology: Diversity, plasticity, and role in neurological diseases.
Zhou B; Zuo YX; Jiang RT
CNS Neurosci Ther; 2019 Jun; 25(6):665-673. PubMed ID: 30929313
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
Toledo A; Grieger E; Karram K; Morrison H; Baader SL
PLoS One; 2018; 13(5):e0196726. PubMed ID: 29715273
[TBL] [Abstract][Full Text] [Related]
19. Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.
Bassiri K; Ferluga S; Sharma V; Syed N; Adams CL; Lasonder E; Hanemann CO
EBioMedicine; 2017 Feb; 16():76-86. PubMed ID: 28126595
[TBL] [Abstract][Full Text] [Related]
20. Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.
Zoch A; Mayerl S; Schulz A; Greither T; Frappart L; Rübsam J; Heuer H; Giovannini M; Morrison H
PLoS One; 2015; 10(8):e0129151. PubMed ID: 26258444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
